Cosmo Pharmaceuticals NV (CHIX:COPNz)
CHF 70.8 -1.1 (-1.53%) Market Cap: 1.16 Bil Enterprise Value: 1.11 Bil PE Ratio: 109.92 PB Ratio: 2.75 GF Score: 66/100